🎉 Finosauras is now  SarasRead more
Bliss GVS Pharma Ltd logo

Bliss GVS Pharma Ltd - Share Price Target 2026

(NSE: BLISSGVS)

Sector: Healthcare

Market Cap: 1646.10 Cr

164.74

-

180.24

Target Price Range

171.23

+4.36 (2.55%)

CMP

Bullish

As on 5 Dec 2025, 03:30 pm

Market Trends

Based on 6 technical indicators.
Bullish4
Bearish0
Neutral2
Agg. Profit Potential0.76%
Agg. Risk 17.34%

Last updated on: 06/12/2025, 3:30 pm

Returns

PeriodReturn %
1 Month-3.20
3 Months25.86
1 Year33.52
5 Years16.76

Last updated on: 06/09/2025, 9:30 AM

Institutional Holdings

InstitutePercentageNo. of Shares
ARIAN INVESTMENT LIMITED7.43%7,853,888
LIFE INSURANCE CORPORATION OF INDIA5.98%6,313,598
COEUS GLOBAL OPPORTUNITIES FUND1.76%1,859,594
ARK GLOBAL EMERGING COMPANIES, LP1.71%1,806,267

Last updated on: 9/30/2025, 12:00:00 AM

Loading technical analysis...

Fundamental Data

Fundamental Analysis

P/E Ratio

21.01

P/B Ratio

1.49

PEG Ratio

0.51

ROE

6.78%

EPS

7.41

Dividend Yield

0.32%

Market Cap

1646.10 Cr

Sector

N/A

Last Updated: 12 Nov 2025, 01:30 pm

Peer Comparison

CompanySentimentTarget PriceUpside

About : Bliss GVS Pharma Ltd.

Incorporated Year

1984

City and State

Mumbai, Maharashtra

Listing Date

Director's Name

Vibha Gagan Sharma

Revenue

66720.46 Cr

Net Profit

9417.11 Cr